Home/Filings/4/0001415889-24-029633
4//SEC Filing

Multani Pratik S 4

Accession 0001415889-24-029633

CIK 0001796280other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:22 PM ET

Size

14.1 KB

Accession

0001415889-24-029633

Insider Transaction Report

Form 4
Period: 2024-12-15
Multani Pratik S
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2024-12-158,0008,000 total
    Common Stock (8,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-15+24,04255,615 total
  • Sale

    Common Stock

    2024-12-16$8.28/sh8,850$73,29346,765 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-12-156,0420 total
    Common Stock (6,042 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-12-1510,00020,000 total
    Common Stock (10,000 underlying)
Footnotes (7)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock.
  • [F2]Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
  • [F3]Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
  • [F4]Represents the weighted average share price of an aggregate total of 8,850 shares sold in the price range of $8.27 to $8.41 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024.
  • [F6]1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025.
  • [F7]1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026.

Issuer

Oric Pharmaceuticals, Inc.

CIK 0001796280

Entity typeother

Related Parties

1
  • filerCIK 0001586894

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:22 PM ET
Size
14.1 KB